Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Sector Catalysts

Jones Act

The law requiring goods shipped between U.S. ports to move on American-built, -crewed, -flagged vessels.

Also known as: Merchant Marine Act of 1920, Cabotage Law

What it is
The Jones Act requires that cargo transported between U.S. ports travel on vessels built, owned, flagged, and crewed by Americans. It protects the domestic maritime industry. Waivers are occasionally granted in emergencies.
What it does
The law guarantees demand for U.S. shipbuilders and domestic carriers, especially in coastal, offshore-wind, and Puerto Rico trades. Waiver debates and offshore-wind buildout are catalysts. Investors watch policy and vessel-supply dynamics.
The evidence
Offshore-wind projects have driven demand for Jones Act-compliant vessels, benefiting U.S. shipbuilders and specialized vessel operators.
Best for
U.S. shipbuilders and carriers: HII, MATX (Matson), KEX (Kirby).
Pairs well with
buy-american, appropriations, ndaa
Use cautiously with
Waivers and limited vessel supply complicate the thesis; assuming the Act guarantees smooth capacity ignores fleet shortages.
Cautions
Repeal proposals surface periodically, adding policy risk to the protected franchise.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More sector catalysts

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →